NYSEHEALTHCARE

Johnson & JohnsonJNJ

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

📊 Key Metrics

P/E Ratio
20.49
What does this mean?

The P/E ratio tells you how much investors pay for each dollar of earnings. A lower P/E might mean the stock is undervalued — or that growth is slowing. Compare it to the industry average for context.

EPS (TTM)
$11.04
What does this mean?

Earnings Per Share (EPS) shows how much profit the company makes for each share you own. Higher EPS generally means more profitable. If EPS is growing year over year, that's a good sign.

Dividend Yield
2.25%
What does this mean?

Dividend yield tells you what percentage of the stock price you'll get back annually in cash payments. A 3% yield means $3 per year for every $100 invested. Great for passive income.

Market Cap
$545.02B
What does this mean?

Market cap is the total value of all shares. Large-cap ($10B+) companies are usually more stable. Mid-cap ($2-10B) offer growth potential. Small-cap (under $2B) are riskier but can grow fast.

52-Week Low
$142.16
52-Week High
$251.71
Beta
0.33
What does this mean?

Beta measures volatility compared to the market. Beta of 1.0 = moves with the market. Above 1.0 = more volatile (bigger swings). Below 1.0 = more stable. Choose based on your risk tolerance.

Profit Margin
21.80%
What does this mean?

Profit margin shows what percentage of revenue becomes actual profit. Higher is better — it means the company keeps more of each dollar it earns. Compare to industry peers.

📋 Detailed Fundamentals

Forward P/E20.00
PEG Ratio3.01
Book Value$33.87
Price to Book6.81
Return on Equity35.00%
Revenue Growth (YoY)9.90%
Analyst Target Price$252.42
Dividend Per Share$5.20
IndustryDRUG MANUFACTURERS - GENERAL
SectorHEALTHCARE

Data provided by Alpha Vantage. Last updated: 4/22/2026, 5:28:51 PM.

This is not financial advice. Always do your own research before investing.